{
    "id": 13122,
    "fullName": "SND1 - BRAF",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SND1-BRAF results from the fusion of SND1 and BRAF, leads to increased Mek and Erk phosphorylation and cell proliferation, is transforming in culture (PMID: 25985019). SND1-BRAF has been identified in lung adenocarcinoma (PMID: 25985019).",
            "references": [
                {
                    "id": 3750,
                    "pubMedId": 25985019,
                    "title": "Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25985019"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 27044,
        "geneSymbol": "SND1",
        "terms": [
            "SND1",
            "p100",
            "TDRD11",
            "Tudor-SN"
        ]
    },
    "variant": "SND1 - BRAF",
    "createDate": "10/13/2015",
    "updateDate": "10/18/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 673,
                "geneSymbol": "BRAF",
                "terms": [
                    "BRAF",
                    "B-raf",
                    "B-RAF1",
                    "BRAF1",
                    "NS7",
                    "RAFB1"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 3527,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a gastric cancer cell line harboring MET amplification and SND1-BRAF was sensitive to the combination of PF-04880594 and PF-0461903 in culture (PMID: 22745804).",
            "molecularProfile": {
                "id": 13346,
                "profileName": "SND1 - BRAF MET amp"
            },
            "therapy": {
                "id": 3152,
                "therapyName": "PF-0461903 + PF-04880594",
                "synonyms": null
            },
            "indication": {
                "id": 5517,
                "name": "stomach carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3751,
                    "pubMedId": 22745804,
                    "title": "A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22745804"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 3526,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a gastric carcinoma cell line harboring MET amplification treated with PF-04217903 eventually developed resistance due to acquisition of the fusion SND1-BRAF, in culture (PMID: 22745804).",
            "molecularProfile": {
                "id": 13346,
                "profileName": "SND1 - BRAF MET amp"
            },
            "therapy": {
                "id": 864,
                "therapyName": "PF-04217903",
                "synonyms": null
            },
            "indication": {
                "id": 5517,
                "name": "stomach carcinoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3751,
                    "pubMedId": 22745804,
                    "title": "A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells through [corrected] MAPK activation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22745804"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 13286,
            "profileName": "SND1 - BRAF",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 13346,
            "profileName": "SND1 - BRAF MET amp",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}